Correlation Engine 2.0
Clear Search sequence regions


Sizes of these terms reflect their relevance to your search.

Tropomyosin (Tpm) is an actin-binding protein that plays a crucial role in the regulation of muscle contraction. Numerous point mutations in the TPM3 gene encoding Tpm of slow skeletal muscles (Tpm 3.12 or γ-Tpm) are associated with the genesis of various congenital myopathies. Two of these mutations, R91P and R245G, are associated with congenital fiber-type disproportion (CFTD) characterized by hypotonia and generalized muscle weakness. We applied various methods to investigate how these mutations affect the structural and functional properties of γγ-Tpm homodimers. The results show that both these mutations lead to strong structural changes in the γγ-Tpm molecule and significantly impaired its functional properties. These changes in the Tpm properties caused by R91P and R245G mutations give insight into the molecular mechanism of the CFTD development and the weakness of slow skeletal muscles observed in this inherited disease. Copyright © 2020 Elsevier Inc. All rights reserved.

Citation

Anastasiia D Gonchar, Galina V Kopylova, Anastasia M Kochurova, Valentina Y Berg, Daniil V Shchepkin, Natalia A Koubasova, Andrey K Tsaturyan, Sergey Y Kleymenov, Alexander M Matyushenko, Dmitrii I Levitsky. Effects of myopathy-causing mutations R91P and R245G in the TPM3 gene on structural and functional properties of slow skeletal muscle tropomyosin. Biochemical and biophysical research communications. 2021 Jan 01;534:8-13

Expand section icon Mesh Tags

Expand section icon Substances


PMID: 33307294

View Full Text